Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02301039 |
|---|---|
| Brief Title: | SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas |
| First Submitted : | November 17, 2014 |
| First Submitted that Met QC Criteria : | November 21, 2014 |
| First Posted : | November 25, 2014 (Estimate) |
| Results First Submitted : | July 8, 2020 |
| Results First Submitted that Met QC Criteria : | September 25, 2020 |
| Results First Posted : | September 29, 2020 |
| Last Update Submitted that Met QC Criteria : | September 25, 2020 |
| Last Update Posted : | September 29, 2020 |